Repetitive Acute Intermittent Hypoxia for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a treatment called acute intermittent hypoxia (rAIH) can help individuals with long-term spinal cord injuries improve arm and leg movement. Participants will receive either the real rAIH treatment or a sham version, along with training. The trial is open to those who have had a spinal cord injury for at least six months and can move their wrists or grip with one hand. Individuals with ongoing heart or lung issues or other conditions may not qualify. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could enhance rehabilitation options for spinal cord injury patients.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking drugs that affect the central nervous system and lower the seizure threshold, like certain antipsychotics or tricyclic antidepressants.
What prior data suggests that this protocol is safe for spinal cord injury recovery?
Research has shown that repeated exposure to short periods of low oxygen (rAIH) is generally safe for people. Studies have found that rAIH can improve movement and strength in individuals with long-term spinal cord injuries.
One study found that rAIH can cause changes in the nervous system that support recovery. Although considered safe, researchers continue to study its effects on the heart and blood vessels. Overall, rAIH appears to be a promising method to enhance function after a spinal cord injury, with manageable safety concerns.12345Why are researchers excited about this trial?
Researchers are excited about the use of repetitive acute intermittent hypoxia (rAIH) for spinal cord injury because it offers a novel approach that differs from the typical physical therapy and medication regimens currently used. rAIH involves short bursts of low oxygen exposure, which can stimulate the body's natural repair mechanisms and potentially enhance nerve function. This technique could lead to improved outcomes by promoting neural plasticity and recovery in ways that current treatments don't address. Unlike traditional methods that primarily focus on symptom management, rAIH targets the underlying neural pathways, offering a promising complementary strategy for rehabilitation.
What evidence suggests that repeated exposure to acute Intermittent Hypoxia (rAIH) could be effective for spinal cord injury?
Research has shown that repeated exposure to short periods of low oxygen, known as acute intermittent hypoxia (rAIH), can improve limb function after a spinal cord injury. Studies indicate that rAIH increases endurance and strength, particularly in the affected limbs. This method involves brief periods of reduced oxygen, which helps the nervous system adjust and improve. In this trial, participants will receive either rAIH combined with training or a sham version of rAIH with training. For people with spinal cord injuries, this approach has shown promise in restoring movement in both arms and legs. Overall, rAIH appears to be a safe and effective way to aid recovery in those with long-term spinal cord injuries.34567
Who Is on the Research Team?
Monica Perez, PhD
Principal Investigator
Shirley Ryan AbilityLab
Are You a Good Fit for This Trial?
This trial is for adults aged 18-85 with chronic spinal cord injury at or above L2, who can grip with one hand or move their wrist and ankle slightly. It's not for those with uncontrolled medical issues, recent heart problems, pregnancy, seizure history, certain medication use, previous brain injuries or conditions affecting the spine other than SCI.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive repeated exposure to acute Intermittent Hypoxia (rAIH) and training by research staff
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Repeated exposure to acute Intermittent Hypoxia (rAIH)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor
U.S. Department of Education
Collaborator